Literature DB >> 35220349

Risk factors for atrial fibrillation in a multicenter United States clinical cohort of people with HIV infection.

Robin M Nance1, Joseph A C Delaney1,2, James S Floyd1, Michael S Saag3, Richard D Moore4, Jeanne C Keruly4, Mari M Kitahata1, Bridget M Whitney1, W Chris Mathews5, Edward R Cachay5, Greer Burkholder3, Amanda L Willig3, Joseph J Eron6, Sonia Napravnik6, Heidi M Crane1, Susan R Heckbert1.   

Abstract

To assess atrial fibrillation risk factors in people with HIV, we identified incident atrial fibrillation in a large clinical cohort of people receiving care. Compared with 970 controls without atrial fibrillation, the 97 with adjudicated incident atrial fibrillation were older, less likely Hispanic, and had more coronary disease, heart failure, and chronic obstructive pulmonary disease. In multivariable analysis, nonuse of antiretroviral therapy and prescription of antiretroviral regimens with multiple core agents were associated with increased atrial fibrillation risk.
Copyright © 2022 Wolters Kluwer Health, Inc. All rights reserved.

Entities:  

Mesh：

Substances：

Year:  2022        PMID： 35220349      PMCID： PMC9081113          DOI： 10.1097/QAD.0000000000003180

Source DB:  PubMed          Journal:  AIDS        ISSN： 0269-9370            Impact factor:   4.632


  19 in total

1.  Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology.

Authors:  Roberto M Lang; Michelle Bierig; Richard B Devereux; Frank A Flachskampf; Elyse Foster; Patricia A Pellikka; Michael H Picard; Mary J Roman; James Seward; Jack S Shanewise; Scott D Solomon; Kirk T Spencer; Martin St John Sutton; William J Stewart
Journal:  J Am Soc Echocardiogr       Date:  2005-12       Impact factor: 5.251

2.  Prevalence and Associated Stroke Risk of Human Immunodeficiency Virus-Infected Patients With Atrial Fibrillation　- A Nationwide Cohort Study.

Authors:  Hyunjean Jung; Pil-Sung Yang; Eunsun Jang; Hee Tae Yu; Tae-Hoon Kim; Jae-Sun Uhm; Jong-Youn Kim; Jung-Hoon Sung; Hui-Nam Pak; Moon-Hyoung Lee; Gregory Y H Lip; Boyoung Joung
Journal:  Circ J       Date:  2019-10-17       Impact factor: 2.993

3.  Atrial fibrillation and human immunodeficiency virus type-1 infection: a systematic review. Implications for anticoagulant and antiarrhythmic therapy.

Authors:  Daniele Pastori; Ivano Mezzaroma; Pasquale Pignatelli; Francesco Violi; Gregory Y H Lip
Journal:  Br J Clin Pharmacol       Date:  2019-01-11       Impact factor: 4.335

4.  Lessons learned from the design and implementation of myocardial infarction adjudication tailored for HIV clinical cohorts.

Authors:  H M Crane; S R Heckbert; D R Drozd; M J Budoff; J A C Delaney; C Rodriguez; P Paramsothy; W B Lober; G Burkholder; J H Willig; M J Mugavero; W C Mathews; P K Crane; R D Moore; S Napravnik; J J Eron; P Hunt; E Geng; P Hsue; G S Barnes; J McReynolds; I Peter; C Grunfeld; M S Saag; M M Kitahata
Journal:  Am J Epidemiol       Date:  2014-03-11       Impact factor: 4.897

5.  Accuracy of electronic health record data for the diagnosis of chronic obstructive pulmonary disease in persons living with HIV and uninfected persons.

Authors:  Kristina Crothers; Carla V Rodriguez; Robin M Nance; Kathleen Akgun; Shahida Shahrir; Joon Kim; Guy W Soo Hoo; Amir Sharafkhaneh; Heidi M Crane; Amy C Justice
Journal:  Pharmacoepidemiol Drug Saf       Date:  2018-06-20       Impact factor: 2.890

Review 6.  Atrial fibrillation and incidence of dementia: a systematic review and meta-analysis.

Authors:  C S Kwok; Y K Loke; R Hale; J F Potter; P K Myint
Journal:  Neurology       Date:  2011-03-08       Impact factor: 9.910

7.  Clinical course of atrial fibrillation in older adults: the importance of cardiovascular events beyond stroke.

Authors:  Jonathan P Piccini; Bradley G Hammill; Moritz F Sinner; Adrian F Hernandez; Allan J Walkey; Emelia J Benjamin; Lesley H Curtis; Susan R Heckbert
Journal:  Eur Heart J       Date:  2013-11-25       Impact factor: 29.983

8.  Atrial fibrillation and atrial flutter in human immunodeficiency virus-infected persons: incidence, risk factors, and association with markers of HIV disease severity.

Authors:  Jonathan C Hsu; Yongmei Li; Gregory M Marcus; Priscilla Y Hsue; Rebecca Scherzer; Carl Grunfeld; Michael G Shlipak
Journal:  J Am Coll Cardiol       Date:  2013-04-03       Impact factor: 24.094

9.  The Alcohol, Smoking and Substance Involvement Screening Test (ASSIST): development, reliability and feasibility.

Authors: 
Journal:  Addiction       Date:  2002-09       Impact factor: 6.526

10.  Simple risk model predicts incidence of atrial fibrillation in a racially and geographically diverse population: the CHARGE-AF consortium.

Authors:  Alvaro Alonso; Bouwe P Krijthe; Thor Aspelund; Katherine A Stepas; Michael J Pencina; Carlee B Moser; Moritz F Sinner; Nona Sotoodehnia; João D Fontes; A Cecile J W Janssens; Richard A Kronmal; Jared W Magnani; Jacqueline C Witteman; Alanna M Chamberlain; Steven A Lubitz; Renate B Schnabel; Sunil K Agarwal; David D McManus; Patrick T Ellinor; Martin G Larson; Gregory L Burke; Lenore J Launer; Albert Hofman; Daniel Levy; John S Gottdiener; Stefan Kääb; David Couper; Tamara B Harris; Elsayed Z Soliman; Bruno H C Stricker; Vilmundur Gudnason; Susan R Heckbert; Emelia J Benjamin
Journal:  J Am Heart Assoc       Date:  2013-03-18       Impact factor: 5.501
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.